Paper of the Month – Selected and discussed by Ulrike von Arnim

The study demonstrates that EoE is no longer a rare disease and represents a growing clinical and economic burden on the healthcare system.

This study compared short-term effectiveness of proton pump inhibitors (PPI), swallowed topical corticosteroids (STC), and dietary therapies in reversing clinical and histological features in pediatric patients with eosinophilic esophagitits (EoE).

In the realm of eosinophilic esophagitis (EoE), the absence of comprehensive studies and clear recommendations regarding optimal monitoring strategies for patients has created a critical gap in clinical practice. ...

APT-1011 is an oral disintegrating tablet (ODT) formulation of fluticasone propionate developed by Ellodi/Adare Pharmaceuticals and designed to disintegrate after put on the tongue without water...

Eosinophilic gastrointestinal disorders (EGIDs) are emerging inflammatory diseases which may involve any part of the gastrointestinal (GI) tract and lead to the eosinophilic mucosal infiltration in the absence of secondary causes of intestinal eosinophilia...